期刊文献+

Wortmannin对人髓母细胞瘤细胞系Daoy增殖和凋亡的影响

Effects of Wortmannin on proliferation and apoptosis of medulloblastoma cell line Daoy
下载PDF
导出
摘要 目的:探讨PI3K抑制剂Wortmannin在体外对人髓母细胞瘤细胞系Daoy增殖和凋亡的影响。方法:Wortmannin作用髓母细胞瘤细胞系Daoy后,CCK-8检测细胞增殖情况,流式细胞仪分析细胞凋亡,Westernblot检测细胞Akt、p-Akt、Cleaved-caspase3的表达,Caspase3活性检测试剂盒观察其活性。结果:不同浓度(0.1、0.25、0.5μmol/L)Wortmannin在体外均能抑制Daoy细胞的增殖,并呈浓度时间依赖性。各浓度Wort-mannin处理细胞48h后,流式细胞仪检测到细胞凋亡率分别为(21.16±2.49)%、(31.02±0.71)%、(44.61±1.47)%,与非处理组比较具有显著差异,并呈剂量依赖;Western blot观察到Wortmannin可使p-Akt表达水平降低,而Cleaved-caspase3明显增高;Caspase3活性检测提示其活性加强。结论:Wortmannin通过抑制PI3K/Akt信号通路活性,激活Caspase3,在体外抑制髓母细胞瘤增殖和诱导凋亡来发挥其抗肿瘤活性。 Objective:To investigate the effects of proliferation and apoptosis induced by Wortmannin in human medulloblastoma cell line Daoy.Methods:Human medulloblastoma cell line Daoy were treated by Wortmannin at different concentration(0.1,0.25,0.5μmol/L) for 24,48,72h,the inhibition rates were determined by CCK-8 assay.Then,the apoptosis rates were evaluated by flow cytometry via Annexin-V/PI labeling.The protein expressions of Akt,p-Akt,Cleaved-caspase3 were detected by western blot analysis.The activity of caspase3 was measured by caspase3 activity assay kit.Results:Wortmannin could inhibit the proliferation of Daoy cells at different concentration(0.1,0.25,0.5μmol/L),and which was in time and dose-dependent manner.After treatment for 48h,flow cytometry found that the apoptosis rates of Daoy cells treated by 0.1,0.25,0.5μmol/L Wortmannin were(21.16 ± 2.49)%,(31.02 ± 0.71)%,(44.61 ± 1.47)%,respectively.It was significantly different,compared with control group.The results of western blot showed that the protein expression of p-Akt was down-regulated,but up-regulation of Cleaved-caspase3 was obvious,which was confirmed by caspase3 activity detection.Conclusion:Wortmannin could inhibit proliferation and induce apoptosis of human medulloblastoma cells via down-regulation of the activity of PI3K/Akt signaling pathway,then up-regulation of caspase3 in vitro.
作者 杨晓非
出处 《现代肿瘤医学》 CAS 2012年第11期2252-2255,共4页 Journal of Modern Oncology
关键词 髓母细胞瘤 渥曼青霉素 细胞凋亡 medulloblastoma Wortmannin proliferation
  • 相关文献

参考文献13

  • 1Scotting PJ,Walker DA,Perilongo G. Childhood solid tumours:a developmental disorder[J].Nature Reviews Cancer,2005,(06):481-488.
  • 2Levine DA,Bogomolniy F,Yee C J. Frequent mutation of the PIK3CA gene in ovarian and breast cancer[J].Clinical Cancer Research,2005,(08):2875-2878.
  • 3Boehle AS,Kurdow R,Boenicke L. Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo[J].Langenbecks Archives of Surgery,2002,(05):234-239.
  • 4Yip WK,Leong VC,Abdullah MA. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor,FKHR and BAD in nasopharyngeal carcinoma[J].Oncology Reports,2008,(02):319-328.
  • 5Altomare DA,Wang HQ,Skele KL. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth[J].Oncogene,2004,(34):5853-5857.doi:10.1038/sj.onc.1207721.
  • 6Schlieman MG,Fahy BN,Ramsamooj R. Incidence,mechanism and prognostic value of activated AKT in pancreas cancer[J].British Journal of Cancer,2003,(11):2110-2115.
  • 7Nyakern M,Tazzari PL,Finelli C. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2006,(02):230-238.
  • 8Pixu Liu,Hailing Cheng,Thomas M. Targeting the phosphoinositide 3-kinase (PBK) pathway in cancer[J].Nature Reviews Drug Discovery,2009,(08):627-644.
  • 9Teranishi F,Takahashi N,Gao N. Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo[J].Cancer Science,2009,(04):770-777.
  • 10李正发,沈晓梅,宋建新,赵仁彬.Wortmannin抑制PI3K途径对K562细胞增殖和Ara-C诱导的细胞凋亡的影响[J].昆明医学院学报,2004,25(4):17-20. 被引量:2

二级参考文献22

  • 1杨大志,姬长友.PI3K、p-Akt蛋白在喉鳞癌中的表达及临床意义[J].第三军医大学学报,2007,29(10):935-937. 被引量:11
  • 2Olsen B B, Bjorling-Poulsen M, Guerra B. Emodin negatively affects the phosphoinosidde 3-kinase/AKT signalling pathway: a study on its mechanism of action[J]. Int J Biochcm Cell Biol, 2007, 39(1) : 227 -237.
  • 3Wipf P, Halter R J. Chemistry and biology of wortmannin[ J]. Org Biomol Chem, 2005, 3 ( 11 ) : 2053 - 2061.
  • 4Isbarn H, Budaus L, Pichlmeier U, et al. Comparison of the effectiveness between long-term instillation of mitomyein C and short-term prophylaxis with MMC or bacille Calmette-Guerin. Study of patients with non-musele-invasive urotbelial cancer of the urinary bladder[ J]. Urologe A, 2008, 47(5 ) : 608 -615.
  • 5Ohta T, Ohmichi M, Hayasaka T, et al. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models[J]. Endocrinology, 2006, 147(4): 1761-1769.
  • 6Katayose K, Seki T, Ohba N, et al. Growth-inhibitory effect of phosphatidylinositol 3-kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family [ J ]. Anticancer Res, 2003, 23 (3B) : 2383 - 2387.
  • 7Ouyang W, Li J, Ma Q, et al. Essential roles of PI-3K/Akt/IKKbeta/ NFkappaB pathway in cyclin D1 induction by arsenite in JB6 C141 cells [J~. Carcinogenesis, 2006, 27(4): 864-873.
  • 8Nicholson K M, Anderson N G. The protein kinase B/Akt signalling pathway in human malignancy [J]. Cell Signal, 2002,14(5) : 381 -395.
  • 9Tsao A S, McDonnell T, Lam S, et al. Increased phospho-AKT(Ser (473)) expression in bronchial dysplasia: implications for tung cancer prevention studies[ J]. Cancer Epidemiol Biomarkers Prey, 2003, 12 (7) : 660 -664.
  • 10Furuya F. Lu C, Willingbam M C, et al. Inhibition of pbosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer [ J]. Carcinogenesis, 2007, 28 (12) : 2451 --2458.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部